CETYA THERAPEUTICS Trademark

Trademark Overview


On Thursday, January 15, 2015, a trademark application was filed for CETYA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CETYA THERAPEUTICS trademark a serial number of 86504253. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 30, 2023. This trademark is owned by Cetya Therapeutics, Inc.. The CETYA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical products in the nature of histone deacetylase (HDAC) inhibitors for the treatment of cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases; pharmaceuticals and pharmaceutical products for treating cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases

Medical research; medical and scientific research services all in the fields of oncology, autoimmune disorders and conditions, hemoglobinopathies, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases
cetya therapeutics

General Information


Serial Number86504253
Word MarkCETYA THERAPEUTICS
Filing DateThursday, January 15, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 30, 2023
Registration Number5105623
Registration DateTuesday, December 20, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CETYA THERAPEUTICS" to the right of a smaller crescent moon inside a larger crescent moon that encompass an orb, all of which form an incomplete circle.
Goods and ServicesPharmaceuticals and pharmaceutical products in the nature of histone deacetylase (HDAC) inhibitors for the treatment of cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases; pharmaceuticals and pharmaceutical products for treating cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CETYA" has no meaning in a foreign language.
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesMedical research; medical and scientific research services all in the fields of oncology, autoimmune disorders and conditions, hemoglobinopathies, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 30, 2023
Primary Code005
First Use Anywhere DateThursday, September 29, 2016
First Use In Commerce DateThursday, September 29, 2016

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 30, 2023
Primary Code042
First Use Anywhere DateThursday, March 31, 2016
First Use In Commerce DateThursday, March 31, 2016

Trademark Owner History


Party NameCetya Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Party NameCetya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Party NameCetya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Trademark Events


Event DateEvent Description
Friday, June 30, 2023CANCELLED SEC. 8 (6-YR)
Monday, December 20, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 20, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, November 12, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 4, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, October 14, 2016USE AMENDMENT FILED
Saturday, October 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 14, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 29, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, January 20, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 20, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, January 20, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, January 14, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, December 8, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, November 23, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 16, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 9, 2015ASSIGNED TO LIE
Tuesday, October 20, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION WRITTEN
Tuesday, April 21, 2015ASSIGNED TO EXAMINER
Thursday, January 29, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 19, 2015NEW APPLICATION ENTERED